A biotech company is turning heads so far during Tuesday’s session after it shared topline analysis of its Phase 2a ...

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

In a turbulent market environment, NAUT Biopharma Inc. has seen its shares tumble to a 52-week low, with the stock price hitting $1.6. According to InvestingPro data, this represents a 39% decline ...

Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as ...

French biotech Inventiva’s layoffs and pipeline shift are expected to help keep the company operational into the second half ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The MAD cohort also saw adverse events such as hair loss and reductions in hemoglobin and neutrophil counts. These side ...

Attorneys general sued the Trump administration to block a NIH decision that would slash grant payments for research overhead ...

On Friday, a separate lawsuit on behalf of the University of California Student Association asked a federal judge in ...

Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...

In January the Arcanum MVCTC FFA Competed in the Ohio FFA Ag Biotechnology State Finals held at the Ohio Department of ...